Brooks Laboratories Q2 Results
- BSE: 533543
- NSE: BROOKS
- ISIN: INE650L01011
- Sector: Major Drugs
BSE
65.52
1.95 (3.07%)
1.95 (3.07%)Volume5.99 K
Updated: Fri 11 Sep, 2026 | 13:05:43
NSE
662.15 (3.37%)
2.15 (3.37%)Volume85.73 K
Updated: Fri 11 Sep, 2026 | 13:41:24
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Brooks Laboratories Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 26 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 21.32 | 21.51 | -6.40% | 19.71 | 8.15% |
| Depreciation/ Amortization | 0.39 | 0.42 | 0.13% | 0.43 | -8.66% |
| Operating Income | 2.13 | 1.45 | -22.10% | 1.08 | 97.49% |
| Net Income | 7.98 | -1.79 | -16.78% | -3.96 | 0.00% |
| Other Operating Expenses Total | 3.29 | 4.20 | 16.44% | 2.87 | 14.40% |
| Net Income Before Taxes | 7.98 | -1.79 | -16.78% | -3.96 | 0.00% |
| Total Revenue | 23.45 | 22.96 | -8.08% | 20.79 | 12.79% |
| Selling/ General/ Admin Expenses Total | 3.93 | 4.21 | 7.08% | 3.21 | 22.30% |
| Diluted Normalized EPS | 2.71 | -0.61 | -16.62% | -1.51 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.